Search results
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 5 days agoIndia. It was widely administered in over 150 countries, including Britain and India. Some studies...
NanoViricides completes Phase 1 trial of lead asset NV-387
Proactive Investors· 5 days agoIt has been found to be active against coronavirus infection, RSV infection, and smallpox and...
Supreme Court to hear Trump immunity claim in election interference case
CNBC· 1 week ago...HHS initiative that has struck deals with several drugmakers in an effort to help speed up the...
Controversial virus-hunting scientist skewered at US COVID-origins hearing
Nature· 5 days agoLawmakers interrogated Peter Daszak over his ties to China and whether his organisation, EcoHealth...
Plea in SC seeks medical panel under retired apex court judge to examine Covishield side effects
Investing.com· 5 days agoPlea in SC seeks medical panel under retired apex court judge to examine Covishield side effects
How many players in a Euro 2024 squad after UEFA extends roster size and when will squads be...
Sporting News· 2 days agoInternational managers have a relatively relaxed job, that is until it's time to select a squad for...
Chinese general takes a harsh line on Taiwan and other disputes at an international naval gathering
Associated Press· 2 weeks agoThe four-day meeting has drawn representatives from partners and competitors including Australia,...
What is at stake in UK local voting ahead of a looming general election
Associated Press· 3 days agoMillions of voters in England and Wales will cast their ballots on Thursday in an array of local...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 5 days agoI Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1...
Who Stands to Gain from a TikTok Ban
New York Times· 2 weeks agoThe Senate has finally passed a law that could bar the video-sharing app in the U.S., leaving some tech giants in pole position to profit — or pounce....